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1 Purpose 
This RFC proposes a standard for the quantitative characterization of miRNA binding sites 
(miRNA-BS) in mammalian cells. The miMeasure standard introduces a ready-to-use standard 
measurement plasmid (pSMB_miMeasure, BBa_K337049) enabling rapid experimental 
characterization of any miRNA-BS of choice. We recommend a new standard unit, RKDU 
(relative knock-down unit) to describe the knock-down efficiency of a miRNA-BS in a specific 
cell type. pSMB_miMeasure allows for an easy and fast measurement of RKDU while providing 
effective normalization against variance stemming from differences in transfection efficiency 
and from other sources. 
 
2 Relation to other RFCs 
This RFC represents an extension of the idea of ensuring measurement comparability via in vivo 
reference standards introduced in RFC 19 by JR Kelly and D Endy. The unit RKDU is closely 
related to the REU standard unit proposed for the characterization of promoters in mammalian 
cells (RFC 41). 
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3 Copyright Notice 
Copyright (C) The BioBricks Foundation (2010).  
 
4 Motivation 
A standard for the quantitative characterization of miRNA-BS is a prerequisite for the systematic 
exploitation of the potential of the cellular miRNA machinery in synthetic biology. An 
exemplary, highly promising application is miTuner - a miRNA based gene expression tuning kit 
for mammalian cells introduced in RCF 72. MiTuner allows fine-tuning of gene expression from 
arbitrary promoters with the help of synthetic miRNAs as well as on/off-targeting based on the 
presence of tissue specific endogenous miRNAs. The potential of miTuner is complemented by 
the quantitative description of miRNA-BS proposed in this RFC. 
Moreover, a method for the quantitative read-out of miRNA-BS properties will facilitate the 
investigation of and the communication about the fundamental processes underlying the miRNA 
machinery in the cell. 
Finally, while many computational approaches have been used to identify miRNA targets 
(Bentwich 2005; Rajewsky 2006; Griffiths-Jones et al. 2008), experimental identification, 
validation and quantitative description of miRNA targets is still a necessary complement for in 
silico approaches. Experimental miRNA-BS characterization will help validate and improve 
current in silico methods. 
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Figure 1: pSMB_miMeasure. A 
bidirectional CMV promoter is driving 
the expression of two reporter genes, 
EGFP and EBFP2, each terminated by 
a SV40 terminator. An ampicillin 
resistance gene allows for selection in 
bacteria.  
5 Rationale 
5.1 Design of pSMB_miMeasure 
The miMeasure standard is based on the 
pSMB_miMeasure plasmid (BBa_K337049, Fig 1): Two 
fluorescent proteins EGFP and EBFP2 are driven by a 
bidirectional CMV promoter to ensure the same 
expression strength for both reporters. This allows for an 
exceptionally effective normalization of varying 
transfection efficiencies and for a highly reproducible 
determination of the RKDU of the binding site of 
interest, as will be explained in further detail below. The 
two fluorescent proteins are destabilized by fusion to a 
MODC degradation domain which leads to a protein half 
life of two hours. The shortened half life of the 
destabilized fluorescent proteins allows for time-laps 
experiments. Furthermore the plasmid contains a BB-2 
(RFC12, RFC41) standard site in the 3' UTR of the 
EGFP to enable user friendly insertion and exchange of the binding site to be measured. The 
plasmid further contains an ampicillin resistance for selection in bacteria. For more details of 
pSMB_miMeasure, refer to http://partsregistry.org/Part:BBa_K337049. The pSMB_miMeasure 
plasmid was submitted to the Registry of Standard Biology Parts with no miRNA-BS insert. 
5.2 RKDU – a standard unit for miRNA-BS characterization 
We introduce the new measurement unit RKDU (relative knock-down unit) as an extension to the 
principle of in vivo reference standard-based part characterization introduced in RFC 19 by JR 
Kelly and D Endy. The RKDU unit is furthermore closely related to the REU unit for the 
description of promoter activity (RFC 41). pSMB_Measure MUST be used for the measurement 
of RKDU.  
We denote the amount of EGFP mRNA transcribed from pSMB_Measure as MEGFP if no 
miRNA-BS is inserted, and as MEGFP_miRNA if the miRNA-BS of interest is inserted. 
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Analogously, we denote the amount of totally folded EGFP as PEGFP respectively PEGFP_miRNA. 
Finally, we describe the amount of EBFP2 mRNA as MEBFP2 and define PEBFP2 as described 
above. 
PEGFP and PEGFP_miRNA MUST be normalized by division through PEBFP2. The normalized protein 
amounts are denoted as PEGFP* and PEGFP_miRNA*: 
     
  
     
      
 
           
  
           
      
 
 
We have introduced three factors to guarantee maximal reproducibility of the measurements and 
optimal elimination of transfection variance with the help of this normalization: (1) EGFP and 
EBFP2 are expressed from the same (bidirectional) promoter (2) EGFP and EBFP2 are 
expressed from the same plasmid (3) EGFP and EBFP2 have very similar properties (97 % 
sequence identity on DNA level).  
 
Finally, we can define: 
     
           
 
     
  
 
Please note that RKDU describes the down-regulation mediated by the miRNA-BS only at the 
protein level, but not at the level of mRNA. A proportional relationship between the abundance 
of unblocked mRNA and the measured abundance of EGFP cannot be assumed (Vogel et al. 
2010). RKDU is nevertheless a very useful measure, as for most miRNA applications (e.g. gene 
expression tuning) control of protein levels, not of mRNA levels, is decisive. Please note 
furthermore that the RKDU for a certain miRNA-BS must be measured and designated 
separately for every cell line of interest, as miRNA expression varies between different cell 
types. 
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5.3 Transfection 
Cells SHOULD be prepared in 96-well format with 5*10
3
 cells/well. Transfection SHOULD be 
carried out with 100 ng DNA/well. pSMB_miMeasure containing the binding site of interest 
SHOULD be transfected in at least 4 replicates. On the same plate, cells transfected with 
pSMB_Measure without inserted miRNA binding site MUST be prepared to allow for RKDU 
calculation (see section 5.2) – at least 4 replicates are RECOMMENDED. 
  
5.4 Measuring RKDU by microscopy 
Cells MUST be grown in black 96-well plates. The microscope MUST be equipped with a laser 
to excite at 405 nm (EBFP2) and one to excite at 488 nm (EGFP) to allow for quantitative 
measurement of EGFP and EBFP2 fluorescence. The cells SHOULD be grown in medium not 
containing phenolred. Otherwise the phenolred medium SHOULD be removed before starting 
microscopy measurements. Measurement MUST be carried out after 48 h. 
 
5.5 Measuring RKDU by FACS 
The flow cytometer MUST be equipped with a 488 nm and 405 nm excitation laser. This allows 
for simultaneous and quantitative measurement of EGFP and EBFP2 fluorescence. Before 
measurement, medium MUST be removed, cells MUST be washed with 1xPBS and trypsinized 
with 60 µl of trypsin per well. After 10 minutes incubation at 37 °C in 1x PBS, 1 % BSA MUST 
be added up to a volume of 200 µl per well. Measurement MUST be carried out after 48 h. 
Samples with low cell numbers (1000-3000 cells/well) or transfection efficiencies MUST be 
excluded. 
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